Journal of Vascular and Interventional Radiology Podcasts
The Journal of Vascular and Interventional Radiology has launched a new feature: monthly audio (or video) podcast discussions with authors regarding current journal articles.
Ziv J Haskal, M.D., FSIR, JVIR editor, and Robert K.W. Ryu, M.D., FSIR, JVIR's new media editor, produce the short, focused interviews that are intended to delve into study rationale and design and implications of results for current practice and future research. These broadcasts deliver current and controversial content, meeting briefing and communications.
JVIR podcasts are found here on the SIR Web site and on the JVIR Web site.
2012 JVIR Podcasts
- "Safety of Uterine Artery Embolization in Patients With Preexisting Hydrosalpinx," Nicholas J Petruzzi, M.D.; Jeffrey W McCann, M.D.; Neel A Patel, M.D.; Carin F Gonsalves, M.D. (June);
- "A Formula to Predict the Platelet Count After Partial Splenic Arterial Embolization in Patients With Hypersplenism," Akihiko Osaki; Takeshi Suda, M.D., Ph.D.; Nobuo Waguri; Toru Ishikawa; Takeshi Yokoo; Kenya Kamimura; Yasushi Tamura; Masaaki Takamura; Masato Igarashi; Hirokazu Kawai; Satoshi Yamagiwa; Yutaka Aoyagi (July); and
- "Computed Tomography Appearance of Lung Tumors Treated With Percutaneous Cryoablation," Nobutake Ito, M.D.; Seishi Nakatsuka, M.D.; Masanori Inoue, M.D.; Hideki Yashiro, M.D.; Sota Oguro, M.D.; Yotaro Izumi, M.D.; Masafumi Kawamura, M.D.; Hiroaki Nomori, M.D.; Sachio Kuribayashi, M.D. (August).
Please send your comments or ideas about the JVIR podcasts to JVIR@SIRweb.org.
Jon C. Davidson, M.D., and Indravadan J. Patel, M.D., both at Case Western Reserve University School of Medicine in Cleveland, Ohio, discuss the recent revision of the SIR standards of care guidelines for coagulation status and hemostasis risk.
Ron C. Gaba, M.D., University of Illinois Medical Center at Chicago, talks about his experience with islet cell transplantation for diabetic patients and future challenges to widespread adoption.
Read "Pancreatic Islet Cell Transplantation: Update for Interventional Radiologists" by Ron C Gaba, M.D.; Raquel Garcia-Roca, M.D.; and Jose Oberholzer, M.D.
Daniel B. Brown, M.D., FSIR, Thomas Jefferson University Hospital, Philadelphia, Pa., discusses "Radiation Emission From Patients Treated With Selective Hepatic Radioembolizations Using Y-90 Microspheres: Are Contact Restrictions Necessary?"
Read the JVIR article.
February's JVIR podcast comes from the ISET symposium on clinical interventional oncology. Aravind Arepally, M.D., FSIR, discusses innovation, device development and commercialization in the IR community.
This month's podcast provides a brief overview and discussion of five featured manuscripts.
"Impact on Renal Function of Percutaneous Thermal Ablation of Renal Masses in Patients With Pre-existing Chronic Kidney Disease," by Wehrenberg-Klee et. al. shows that renal function is unaffected by image-guided renal tumor ablation.
"Temporal Assessment of Splenic Function in Patients Who Have Undergone Percutaneous Image-Guided Splenic Artery Embolization in the Setting of Trauma" by Pirasteh et. al. demonstrates the absence of Howell-Jolly bodies in patients who have undergone splenic artery embolization, which confirms normal splenic function with long-term follow up.
Mandato et. al.'s "Safety of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI): A Report of 257 Patients With Multiple Sclerosis" reports that outpatient interventions for CCSVI can be performed safely, with an acceptable complication profile.
"Outcomes of Patients Undergoing Percutaneous Biliary Drainage to Reduce Bilirubin for Administration of Chemotherapy" by Thornton et. al. reveals that only 30 percent of patients will normalize their bilirubin levels for chemotherapy after percutaneous intervention.
"Radioembolization vs. Standard Care of Hepatic Metastases: Comparative Retrospective Cohort Study of Survival Outcomes and Adverse Events in Salvage Patients" by Bester et. al. retrospectively compares outcomes in two cohorts of liver-dominant metastatic cancer patients: those who were treated with radioembolization and those who were not treated with radioembolization and received best supportive care.
2011 JVIR Podcasts
Steven J. Smith, M.D., LaGrange Memorial Hospital, LaGrange, Ill., discusses vertebroplasty, clinical trials and the placebo effect (December 2011).
Robert J. Lewandowski, M.D., Northwestern Memorial Hospital, Chicago, Ill., discusses the management of optional IVC filters.
Matthew S. Johnson, M.D., FSIR, Indiana University School of Medicine, Indianapolis, Ind., provides a commentary on hepatic arterial consolidation in preparation for Yttrium-90 radioembolization (October 2011).
Here is "Consolidation of Hepatic Arterial Inflow by Embolization of Variant Hepatic Arteries in Preparation for Yttrium-90 Radioembolization." The article may also be found on the JVIR Web site.
James B. Spies, M.D., MPH, FSIR , Georgetown University, Washington, D.C., discusses a "Comparison of Clinical Outcomes of Tris-acryl Microspheres Versus Polyvinyl Alcohol Microspheres for Uterine Artery Embolization for Leiomyomas: Results of a Randomized Trial" (September 2011).
Read the JVIR article.
Shaun L. Samuels, M.D., FSIR, Baptist Cardiac & Vascular Institute, Miami, Fla., explores "Percutaneous Lower-extremity Arterial Interventions With Primary Balloon Angioplasty Versus SilverHawk Atherectomy and Adjunctive Balloon Angioplasty: Randomized Trial" (September 2011).
Read the JVIR article.
Richard Chang, M.D., National Institutes of Health, describes his experience with treating acute DVT with daily intraclot injections of lytic agent and avoiding the complications associated with catheter-directed continuous lytic infusions (August 2011).
James F. Benenati, M.D., FSIR, provides a "10-minute Update on Carotid Stents after CREST" (July 2011).
Michael J. Hall, M.D., discusses "Utility of Noninvasive Aneurysm Sac Pressure Measurement During and After Endovascular Abdominal Aortic Aneurysm Repair" (JVIR, July 2011).
Brian Funaki, M.D., FSIR, offers "Tips for Central Venous Access in Patient With Chronic Central Vein Occlusions" (July 2011).
- Funaki B, Zaleski GX, Leef JA, Lorenz JN, Van Ha T, Rosenblum JD. Radiologic placement of tunneled hemodialysis catheters in occluded neck, chest, or small thyrocervical collateral veins in central venous occlusion. Radiology. 2001 Feb;218(2):471-6
- Powell S, Chan TY, Bhat R, Lam K, Narlawar RS, Cullen N, Littler P. A retrospective comparative study of tunneled haemodialysis catheters inserted through occluded or collateral veins versus conventional methods. Cardiovasc Intervent Radiol. 2010 Aug;33(4):744-50. Epub 2009 Sep 19.
- Farrell T, Lang EV, Barnhart W. Sharp recanalization of central venous occlusions. J Vasc Interv Radiol. 1999 Feb;10(2 Pt 1):149-54.
- Ferral H, Bjarnason H, Wholey M, Lopera J, Maynar M, Castaneda-Zuniga WR. Recanalization of occluded veins to provide access for central catheter placement. J Vasc Interv Radiol. 1996 Sep-Oct;7(5):681-5.
Funaki B. Unconventional Central Access: Catheter Insertion in Collateral or in Recanalized Veins. Semin Intervent Radiol. 2004 June; 21(2): 111-117.
William T. Kuo, M.D., FSIR: "Photothermal Ablation With the Excimer Laser Sheath Technique for Embedded Inferior Vena Cava Filter Removal: Initial Results From a Prospective Study" (June 2011)
Michael D. Dake, M.D.: "Polymer-free Paclitaxel-coated Zilver PTX Stents - Evaluation of Pharmacokinetics and Comparative Safety in Porcine Arteries" (May 2011)
Kenneth R.Thomson, M.D., FSIR: "Investigation of the Safety of Irreversible Electroporation in Humans" (May 2011)
James R. Duncan, M.D., Ph.D., FSIR: "Optimizing Radiation Use During Fluoroscopic Procedures: Proceedings From a Multidisciplinary Consensus Panel" (April 2011)
Jason C. Smith, M.D.: "Ultra-low-dose Protocol for CT-guided Lung Biopsies" (April 2011)
JVIR Podcasts From SIR's 2011 Annual Scientific Meeting
Kenneth Mandato, M.D., "Safety of Outpatient Endovascular Treatment of the Internal Jugular and Azygos Veins for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis: A Retrospective Analysis"